COSCIENS Biopharma, Inc. (CSCI.TO)
7.50
+0.26
(+3.59%)
CAD |
TSX |
Aug 25, 16:00
COSCIENS Biopharma Debt to Equity Ratio : 0.1318 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1318 |
| March 31, 2026 | 0.1321 |
| December 31, 2025 | 0.5593 |
| September 30, 2025 | 0.4274 |
| June 30, 2025 | 0.3182 |
| March 31, 2025 | 0.2194 |
| December 31, 2024 | 0.1755 |
| September 30, 2024 | 0.0807 |
| June 30, 2024 | 0.0643 |
| March 31, 2024 | 0.018 |
| December 31, 2023 | 0.0807 |
| September 30, 2023 | 0.0083 |
| June 30, 2023 | 0.0079 |
| March 31, 2023 | 0.0067 |
| December 31, 2022 | 0.005 |
| September 30, 2022 | 0.0018 |
| June 30, 2022 | 0.0022 |
| March 31, 2022 | 0.0031 |
| December 31, 2021 | 0.003 |
| September 30, 2021 | 0.0033 |
| June 30, 2021 | 0.0019 |
| March 31, 2021 | 0.0022 |
| December 31, 2020 | 0.0139 |
| September 30, 2020 | 0.0133 |
| June 30, 2020 | 0.2385 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2134 |
| December 31, 2019 | -0.3683 |
| September 30, 2019 | -0.4797 |
| June 30, 2019 | -0.4673 |
| March 31, 2019 | -0.4938 |
| December 31, 2018 | 0.387 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Spectral Medical, Inc. | -0.3529 |
| Resverlogix Corp. | -0.8247 |
| Theratechnologies, Inc. | -- |
| Restart Life Sciences Corp. | 0.2294 |
| Defence Therapeutics Inc | 0.2889 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 26.74M |
| Total Liabilities (Quarterly) | 5.688M |
| Shareholders Equity (Quarterly) | 21.06M |
| Current Ratio | 4.328 |
| Net Debt Paydown Yield | 0.83% |